Avidity Partners Management LP 13D and 13G filings for Context Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-11-14 5:31 pm Unchanged | 2024-09-30 | 13G | Context Therapeutics Inc. CNTX | Avidity Partners Management LP | 7,776,296 9.900% | 0 (Unchanged) | Filing |
2024-05-13 10:37 am Purchase | 2024-05-02 | 13G | Context Therapeutics Inc. CNTX | Avidity Partners Management LP | 7,776,296 9.900% | 7,776,296 (New Position) | Filing |